| Literature DB >> 22301145 |
Zandrea Ambrose1, KyeongEun Lee, Jean Ndjomou, Hongzhan Xu, Ilker Oztop, James Matous, Taichiro Takemura, Derya Unutmaz, Alan Engelman, Stephen H Hughes, Vineet N KewalRamani.
Abstract
The antiviral factor CPSF6-358 interferes with the nuclear entry of human immunodeficiency virus type 1 (HIV-1). HIV-1 acquires resistance to CPSF6-358 through the N74D mutation of the capsid (CA), which alters its nuclear entry pathway. Here we show that compared to wild-type (WT) HIV-1, N74D HIV-1 is more sensitive to cyclosporine, has increased sensitivity to nevirapine, and is impaired in macrophage infection prior to reverse transcription. These phenotypes suggest a difference in the N74D reverse transcription complex that manifests early after infection and prior to interaction with the nuclear pore. Overall, our data indicate that N74D HIV-1 replication in transformed cells requires cyclophilin A but is dependent on other interactions in macrophages.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22301145 PMCID: PMC3318671 DOI: 10.1128/JVI.05887-11
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103